11/14/2011
https://congress.gov...
"The OPEN Act has the potential to result in hundreds of new drugs and treatments for individuals with rare diseases."
"As you know, combination products are products on the market that have elements of a medical device and a drug, like inhalers and insulin injectors."
"Last month my colleague and I, G.K. Butterfield, introduced the OPEN Act for the second time."
"So physicians have to schedule their own appointments?"